Neuberger Berman Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.91M Buy
275,575
+23,811
+9% +$756K 0.01% 944
2026
Q1
$7.85M Buy
251,764
+237,857
+1,710% +$7.49M 0.01% 874
2025
Q4
$410K Buy
13,907
+1,246
+10% +$34.6K ﹤0.01% 1698
2025
Q3
$320K Buy
12,661
+937
+8% +$22.8K ﹤0.01% 1737
2025
Q2
$281K Sell
11,724
-3,156
-21% -$73.2K ﹤0.01% 1753
2025
Q1
$341K Sell
14,880
-320,154
-96% -$7.73M ﹤0.01% 1658
2024
Q4
$8.45M Buy
335,034
+128,843
+62% +$3.26M 0.01% 843
2024
Q3
$5.18M Buy
206,191
+37,096
+22% +$1.1M ﹤0.01% 935
2024
Q2
$5.01M Sell
169,095
-99,095
-37% -$2.75M ﹤0.01% 907
2024
Q1
$8.1M Sell
268,190
-193,544
-42% -$5.37M 0.01% 826
2023
Q4
$13.2M Buy
461,734
+443,794
+2,474% +$13M 0.01% 844
2023
Q3
$665K Sell
17,940
-91
-0.5% -$3.48K ﹤0.01% 1376
2023
Q2
$703K Sell
18,031
-2,316
-11% -$90.8K ﹤0.01% 1344
2023
Q1
$743K Sell
20,347
-81
-0.4% -$2.56K ﹤0.01% 1339
2022
Q4
$629K Buy
+20,428
New +$634K ﹤0.01% 1379

Other funds holding RTO

Neuberger Berman Group's RTO Position: Q2 2026 in Review

Neuberger Berman Group increased its Rentokil (RTO) stake by 9.5% in Q2 2026, buying an estimated $756K and bringing the position to 275,575 shares worth $7.91M. The position accounts for 0.01% of the portfolio, ranked #944.

Neuberger Berman Group first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.2M in Q4 2023. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Neuberger Berman Group held 275,575 shares of Rentokil worth $7.91M as of Q2 2026.
  • Neuberger Berman Group bought 23,811 Rentokil shares in Q2 2026, an estimated $756K.
  • Rentokil made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #944 holding.
  • Neuberger Berman Group first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
  • Neuberger Berman Group's Rentokil position peaked at $13.2M in Q4 2023.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.